Hundreds enrolled in Canadian HIV trials

June 1997
CMAJ: Canadian Medical Association Journal;06/15/97, Vol. 156 Issue 12, p1691
Academic Journal
Reports on the Canadian volunteers enrolled in a protease inhibitor study that is the first large-scale collaborative clinical trial involving the Canadian HIV Trials Network (CTN) and American researchers. Comparison of the effectiveness of a 2-drug combinations with AZT against the highest dose of etoposide and doxoruobicin with VACOP-B combination chemotherapy; Breadth of HIV trials in Canada.


Related Articles

  • New drugs to fight resistant HIV near market.  // Indianapolis Business Journal;10/04/99, Vol. 20 Issue 29, p21 

    Focuses on the impending market introduction of drugs to fight HIV infections after the final findings of clinical trials. Drug companies with the new drug developments; Gene-testing technology used for the drugs.

  • Microbicide Research Will Prevail Despite Most Recent Setback, Experts Say.  // AIDS Alert;Jul2007, Vol. 22 Issue 7, Special section p1 

    The article focuses on the impact of the cancellation of a phase III clinical trial studying cellulose sulfate to block HIV infection on microbicide research in the U.S.

  • Microbicide candidate found safe, but not effective -- What's the next step in research? Bowers, Rebecca // Contraceptive Technology Update;May2008 Supplement, Vol. 29, p1 

    The article reports that the first effectiveness trial for a microbicide indicate that while Carraguard is safe to use, it is not effective in the prevention of male-to-female HIV transmission.

  • The Quest Trial, a paradigm of HIV collaborative research. Goh, Li-Ean; McDade, Hugh; Kinloch, Sabine; Perrin, Luc; Cooper, David; Phillips, Andrew; Hoen, Bruno; Autran, Brigitte; Sonnerborg, Anders; Tsoukas, Chris // Nature Medicine;Nov2000, Vol. 6 Issue 11, p1194 

    Presents an example of a clinical trial involving multi-party collaboration. GlaxoWellcome's initiation of an international study to assess whether highly active anti-retroviral therapy administered to patients with HIV-1 would allow for long-term control of viral replication whe treatment was...

  • Scientific and Ethical Considerations in Trial Design for Investigational Agents for the Treatment of Human Immunodeficiency Virus Infection. Feinberg, Judith; Japour, Anthony J. // Clinical Infectious Diseases;1/15/2003, Vol. 36 Issue 2, p201 

    The design of clinical trials for new antiretroviral agents poses unique challenges, given the availability of highly active antiretroviral therapy (HAART). These challenges include the selection of appropriate populations, the methods used to partition the effects of the study drug under...

  • HIV antibodies 'have potent impact'.  // Africa Health;Nov2013, Vol. 36 Issue 1, p15 

    The article informs that the clinical trials for a new HIV treatment method would take place in the U.S. after it was found that the method had a major impact on the virus and was able to wipe out a hybrid of human and monkey immunodeficiency viruses from blood stream of monkey within days.

  • Deaths bring South African HIV drug trials to a premature halt. Cherry, Michael // Nature;4/13/2000, Vol. 404 Issue 6779, p695 

    Reports on the suspension of the clinical trials of HIV drug Coviracil in South Africa following the deaths of test subjects. Clinical trial of the antiretroviral drug in combination with d4t and nevirapine drugs; Refusal of the government to supply anti-HIV drugs to pregnant women.

  • TRIALS CANCELED FOR SORIVUDINE.  // AIDS Patient Care & STDs;Aug98, Vol. 12 Issue 8, p647 

    Reports that sorivudine will no longer be used in clinical trials, despite its effectiveness in treating herpes zoster in patients with human immunodeficiency virus (HIV) infection. Results of study conducted by Dr. John W. Gnann Jr. and colleagues at the University of Alabama in Birmingham;...

  • Examination of an interventionist-led HIV intervention among criminal justice-involved female prisoners. Havens, Jennifer R.; Leukefeld, Carl G.; Oser, Carrie B.; Staton-Tindall, Michele; Knudsen, Hannah K.; Mooney, Jennifer; Duvall, Jamieson L.; Clarke, Jennifer G.; Frisman, Linda; Surratt, Hilary L.; Inciardi, James A. // Journal of Experimental Criminology;Sep2009, Vol. 5 Issue 3, p245 

    The purpose of this study was to examine the implementation, adherence and protocol fidelity for the Reducing Risky Relationships for HIV (RRR-HIV) study. The RRR-HIV study is a phase III trial of a randomized intervention to reduce human immunodeficiency virus (HIV) risk behaviors among...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics